Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China

Current knowledge regarding the long-term humoral response of people infected with human immunodeficiency virus to the third dose of inactivated coronavirus disease (COVID-19) vaccine is incomplete. As a result, concerns remain about the safety and efficacy of the vaccination. To improve our underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Yunyun, Han, Xiaoxu, Cui, Xinyu, Wang, Peng, Wang, Xin, Liu, Hui, Wang, Yuqi, Zhu, Na, Li, Yanyan, Lin, Yingying, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302496/
https://www.ncbi.nlm.nih.gov/pubmed/37376408
http://dx.doi.org/10.3390/vaccines11061019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302496/
https://www.ncbi.nlm.nih.gov/pubmed/37376408
http://dx.doi.org/10.3390/vaccines11061019

Ejemplares similares